The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration

AIDS

Volumn 13, Issue 4, 1999, Pages 487-494

  Hoffman, Irving F ^a,e   Jere, Charles S ^b   Taylor, Terrie E ^c   Munthali, Peter ^b   Dyer, John R ^a   Wirima, Jack J ^b   Rogerson, Stephen J ^d   Kumwenda, Newton ^d   Eron, Joe J ^a   Fiscus, Susan A ^a   Chakraborty, Hrishitesh ^a   Taha, Taha E ^d   Cohen, Myron S ^a   Molyneux, Malcolm E ^d  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF MALAWI   (Malawi)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d QUEEN ELIZABETH CENTRAL HOSPITAL   (Malawi)

^e UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; AIDS RELATED COMPLEX; ANIMAL; ARTICLE; BLOOD; FEMALE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MALARIA FALCIPARUM; MALE; PROSPECTIVE STUDY; VIROLOGY; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; FEMALE; HIV-1; HUMANS; MALARIA, FALCIPARUM; MALE; PROSPECTIVE STUDIES; RNA, VIRAL; VIRAL LOAD;

EID: 0033545480     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199903110-00007     Document Type: Article

References (40)

1. Mellors IW, Rinaldo CR, Gupta P. et al.; Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170.
2. Gerberding IL: Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis 1994, 170:1410-1417.
3. Lang G, Burger H, Grimson R, et al.; Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci U S A 1995, 92:12100-12104.
4. Lee IH, Sakahara N, Fiebig E, Busch MP, O'Brien TR, Herman SA: Correlation of HIV-1 from RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12:427-428.
5. Dyer JR, Kazembe P, Vernazza PL, et al.: High levels of HIV-1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis 1998, 177:1742-1746.
6. Anzala OA, Nagelkerke NJD, Bwayo JJ, et al.: Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995, 171:686-689.
7. Morgan D, Maude GH, Malamba SS, Okongo MJ, Wagner H-U, Mulder DW, Whitworth JA: HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 1997, 350:245-250.
8. Del Amo J, Petruckevitch A, Phillips AN, et al.: Spectrum of disease in Africans with AIDS in London. AIDS 1996, 10:1563-1569.
9. Del Amo J, Petruckevitch A, Phillips AN, et al.: Disease progression and survival in HIV-1-infected Africans in London. AIDS 1998, 12:1203-1209.
10. Goletti D, Weissman D, Jackson RW, et al.: Effect of Mycobacterium tuberculosis on HIV replication. J Immunol 1996, 157:1271-1278.
11. Mole L, Ripich S, Margolis D, Holodniy M: The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997, 176:766-770.
12. Bush CE, Donovan RM, Markowitz NP, et al.: A study of HIV viral load in AIDS patients with bacterial pneumonia. J AIDS Hum Retrovir 1996, 13:23-26.
13. + T cells is markedly enhanced in the setting of antigen-specific immune activation. J Exp Med 1996, 183:687-692.
14. Vicenzi E, Poli G: Regulation of HIV expression by viral genes and cytokines. J Leukoc Biol 1994, 56:328-334.
15. Morrow RH, Colebunders RL, Chin J: Interactions of HIV infection with endemic tropical diseases. AIDS 1989, 3 (Suppl. 1):S79-87.
16. Global AIDS surveillance. Wkly Epidemiol Rec 1997, 72:197-198.
17. World malaria situation in 1994, part III. Wkly Epidemiol Rec 1997, 72:285-290.
18. Bernard RP, Zellweger U, Wang J, Somaini B: UNAIDS, AIDS Feedback Report; 1997.
19. Kalyesubula I, Musoke-Mudido P, Marum L, Bagenda D, Aceng E, Ndugwa C: Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children. Pediatr Infect Dis J 1997, 16:876-881.
20. Taha TET, Canner JK, Dallabetta GA, et al.: Childhood malaria parasitemia and human immunodeficiency virus infection in Malawi. Trans R Soc Trop Med Hyg 1994, 88:164-165.
21. Niyongabo T, Deloran P, Aubry P, et al.: Prognostic indicators in adult cerebral malaria: a study in Burundi, an area of high prevalence of HIV infection. Acta Tropica 1994, 56:299-305.
22. Greenberg AE, Nsa W, Ryder RW, et al,; Plasmodium falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasha, Zaire. N Engl J Med 1991, 325:105-109.
23. Muller O, Moser R: The clinical and parasitological presentation of Plasmodium falciparum malaria in Uganda is unaffected by HIV-1 infection. Trans R Soc Trop Med Hyg 1990, 84:336-338.
24. Colebunders R, Bahwe Y, Nekwei W, et al.: Incidence of malaria and efficiency of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasha, Zaire. J Infect 1990, 21:167-173.
25. Simooya OO, Mwendapole RM, Siziyj S, Fleming AF. Relationship between falciparum malaria and HIV seropositivity in Ndola, Zambia. BMJ 1988, 297:30-31.
26. Nguyen-Dinh P, Greenberg AE, Mann JM, et al.: Absence of association between Plasmodium falciparum malaria and human immunodeficiency virus infection in children in Kinshasa, Zaire. Bull WHO 1987, 65:607-613.
27. French N, Lugadda E, Watera C, Nakiyinga J, Carpenter L, Gilks CT: Falciparum malaria and its association with immune status in a cohort of HIV-1 infected adults in Entebbe, Uganda. 12th World AIDS Conference. Geneva, 28 June-3 July, 1998 [abstract 130*/22236].
28. Bloland PB, Wirima JJ, Steketee RW, et al.: Maternal HIV infection and infant mortality in Malawi; evidence for increased mortality due to placental malaria infection. AIDS 1995, 9:721-726.
29. Xiao TH, Owen SM, Rudolph DL, Lal RB, Lal AA: Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha. J Infect Dis 1998, 177:437-445.
30. Trape JF: Rapid evaluation of malaria parasite density and standardization of thick smear examination for epidemiological investigations. Trans R Soc Trop Med Hyg 1985, 79:181-184.
31. Organon-Technica: NucliSens, manufacturers package insert, 1998.
32. Warrell DA, Molyneux M, Beales P: Severe and complicated malaria. Trans R Soc Trop Med Hyg 1990, 84 (Suppl. 2): 1 -69.
33. Coombs RW, Welles SC, Hooper C, et al.: Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. J Infect Dis 1996, 174:704-712.
34. Welles SC, Jackson B, Yen-Lieberman, et al.: Prognostic value of plasma HIV type 1 RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. J Infect Dis 1996, 174:696-703.
35. Grau GE, Taylor TE, Molyneux ME: Tumor necrosis factor in children with falciparum malaria. N Engl J Med 1989, 320:1586-1591.
36. Kern P, Hemmer CJ, Damme JV, Gruss HJ, Dietrich M: Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med 1989, 87:139-143.
37. Wahlgren M, Abrams JS, Fernandez V, et al.: Adhesion of Plasmodium falciparum-infected erythrocytes to human cells and secretion of cytokines. Scand J Immunol 1995, 42:626-663.
38. Perelson AS, Essunger P, Ho DD: Dynamics of HIV-1 and CD4+ lymphocytes in vivo. AIDS 1997, 11 (Suppl. A):S17-24.
39. Worku S, Bjorkman A, Troye-Blomberg M, Jemaneh L, Farnert A, Christensson B: Lymphocyte activation and subset redistribution in the peripheral blood in acute malaria illness: distinct T cell patterns in Plasmodium falciparum and P. vivax infections. Clin Exp Immunol 1997, 108:34-41.
40. Chougnet C, Tallet S, Ringwald P, Deloren P: Kinetics of lymphocyte subsets from peripheral blood during a Plasmodium falciparum malaria attack. Clin Exp Immunol 1992, 90:405-408.